Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Glycobiology ; 21(5): 634-43, 2011 May.
Artigo em Inglês | MEDLINE | ID: mdl-21186285

RESUMO

N-Glycosylation affects the function of ion channels at the level of multisubunit assembly, protein trafficking, ligand binding and channel opening. Like the majority of membrane proteins, ionotropic P2X receptors for extracellular ATP are glycosylated in their extracellular moiety. Here, we used site-directed mutagenesis to the four predicted N-glycosylation sites of P2X(3) receptor (Asn(139), Asn(170), Asn(194) and Asn(290)) and performed comparative analysis of the role of N-glycans on protein stability, plasma membrane delivery, trimer formation and inward currents. We have found that in transiently transfected HEK293 cells, Asn(170) is apparently the most important site for receptor stability, since its mutation causes a primary loss in protein content and indirect failure in membrane expression, oligomeric association and inward current responses. Even stronger effects are obtained when mutating Thr(172) in the same glycosylation consensus. Asn(194) and Asn(290) are the most dispensable, since even their simultaneous mutation does not affect any tested receptor feature. All double mutants containing Asn(170) mutation or the Asn(139)/Asn(290) double mutant are instead almost unable to assemble into a functional trimeric structure. The main emerging finding is that the inability to assemble into trimers might account for the impaired function in P2X(3) mutants where residue Asn(170) is replaced. These results improve our knowledge about the role of N-glycosylation in proper folding and oligomeric association of P2X(3) receptor.


Assuntos
Trifosfato de Adenosina/análogos & derivados , Processamento de Proteína Pós-Traducional/genética , Receptores Purinérgicos P2X3/metabolismo , Trifosfato de Adenosina/farmacologia , Sequência de Aminoácidos , Substituição de Aminoácidos , Animais , Glicosilação , Células HEK293 , Humanos , Leupeptinas/farmacologia , Potenciais da Membrana/efeitos dos fármacos , Dados de Sequência Molecular , Peptídeo-N4-(N-acetil-beta-glucosaminil) Asparagina Amidase/metabolismo , Complexo de Endopeptidases do Proteassoma , Inibidores de Proteassoma , Multimerização Proteica , Ratos , Receptores Purinérgicos P2X3/química , Receptores Purinérgicos P2X3/genética , Alinhamento de Sequência
2.
Neurobiol Dis ; 18(1): 100-9, 2005 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-15649700

RESUMO

Extracellular nucleotides exert a variety of biological actions through different subtypes of P2 receptors. Here we characterized in the human neuroblastoma SH-SY5Y cells the simultaneous presence of various P2 receptors, belonging to the P2X ionotropic and P2Y metabotropic families. Western blot analysis detected the P2X1,2,4,5,6,7 and P2Y1,2,4,6, but not the P2X3 and P2Y12 receptors. We then investigated which biological effects were mediated by the P2Y4 subtype and its physiological pyrimidine agonist UTP. We found that neuronal differentiation of the SH-SY5Y cells with dibutiryl-cAMP increased the expression of the P2Y4 protein and that UTP itself was able to positively interfere with neuritogenesis. Moreover, transient transfection and activation of P2Y4 also facilitated neuritogenesis in SH-SY5Y cells, as detected by morphological phase contrast analysis and confocal examination of neurofilament proteins NFL. This was concurrent with increased transcription of immediate-early genes linked to differentiation such as cdk-5 and NeuroD6, and activity of AP-1 transcription family members such as c-fos, fos-B, and jun-D. Nevertheless, a prolonged activation of the P2Y4 receptor by UTP also induced cell death, both in naive, differentiated, and P2Y4-transfected SH-SY5Y cells, as measured by direct count of intact nuclei and cytofluorimetric analysis of damaged DNA. Taken together, our data indicate that the high expression and activation of the P2Y4 receptor participates in the neuronal differentiation and commitment to death of SH-SY5Y cells.


Assuntos
Neoplasias Encefálicas/metabolismo , Diferenciação Celular/genética , Neuroblastoma/metabolismo , Receptores Purinérgicos P2/metabolismo , Neoplasias Encefálicas/genética , Bucladesina/farmacologia , Morte Celular/efeitos dos fármacos , Morte Celular/genética , Diferenciação Celular/efeitos dos fármacos , Linhagem Celular Tumoral , Transformação Celular Neoplásica/genética , Regulação Neoplásica da Expressão Gênica/genética , Genes Precoces/efeitos dos fármacos , Genes Precoces/genética , Humanos , Neuroblastoma/genética , Proteínas de Neurofilamentos/metabolismo , Agonistas do Receptor Purinérgico P2 , Receptores Purinérgicos P2/genética , Fatores de Transcrição/efeitos dos fármacos , Fatores de Transcrição/genética , Transfecção , Regulação para Cima/efeitos dos fármacos , Regulação para Cima/fisiologia , Uridina Trifosfato/metabolismo , Uridina Trifosfato/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...